Baidu
map

肿瘤第一线 · 学术知识传播

订阅

MedSci主页 / 所有栏目 / 肿瘤第一线 · 学术知识传播

卡培他滨为基础的辅助化疗在结直肠癌中的疗效及相关药物基因组学分析

2021-11-25 李慎柯 李慎柯

肠癌资讯阅读

探讨卡培他滨为基础的辅助化疗在结直肠癌患者中的疗效及相关药物基因组学分析。

版权声明：
本网站所有内容来源注明为“梅斯医学”或“MedSci原创”的文字、图片和音视频资料，版权均属于梅斯医学所有。非经授权，任何媒体、网站或个人不得转载，授权转载时须注明来源为“梅斯医学”。其它来源的文章系转载文章，或“梅斯号”自媒体发布的文章，仅系出于传递更多信息之目的，本站仅负责审核内容合规，其内容不代表本站立场，本站不负责内容的准确性和版权。如果存在侵权、或不希望被转载的媒体或个人可与我们联系，我们将立即进行删除处理。
在此留言
评论区 (3)
#插入话题
  1. [GetPortalCommentsPageByObjectIdResponse(id=1293533, encodeId=a63c12935338f, content=<a href='/topic/show?id=a82f36493c4' target=_blank style='color:#2F92EE;'>#卡培他滨#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=83, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=36493, encryptionId=a82f36493c4, topicName=卡培他滨)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=1c8c241, createdName=w363522449, createdTime=Sat Nov 27 09:03:13 CST 2021, time=2021-11-27, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1453617, encodeId=0970145361e44, content=<a href='/topic/show?id=098ee8679ad' target=_blank style='color:#2F92EE;'>#结直肠#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=74, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=78679, encryptionId=098ee8679ad, topicName=结直肠)], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=9ace5575596, createdName=crystal0564, createdTime=Sat Nov 27 09:03:13 CST 2021, time=2021-11-27, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1469733, encodeId=17d51469e3399, content=<a href='/topic/show?id=09224182601' target=_blank style='color:#2F92EE;'>#基因组学#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=87, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=41826, encryptionId=09224182601, topicName=基因组学)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=c0257060332, createdName=gwc385, createdTime=Sat Nov 27 09:03:13 CST 2021, time=2021-11-27, status=1, ipAttribution=)]
    2021-11-27 w363522449

    #卡培他滨#

    0

  2. [GetPortalCommentsPageByObjectIdResponse(id=1293533, encodeId=a63c12935338f, content=<a href='/topic/show?id=a82f36493c4' target=_blank style='color:#2F92EE;'>#卡培他滨#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=83, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=36493, encryptionId=a82f36493c4, topicName=卡培他滨)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=1c8c241, createdName=w363522449, createdTime=Sat Nov 27 09:03:13 CST 2021, time=2021-11-27, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1453617, encodeId=0970145361e44, content=<a href='/topic/show?id=098ee8679ad' target=_blank style='color:#2F92EE;'>#结直肠#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=74, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=78679, encryptionId=098ee8679ad, topicName=结直肠)], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=9ace5575596, createdName=crystal0564, createdTime=Sat Nov 27 09:03:13 CST 2021, time=2021-11-27, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1469733, encodeId=17d51469e3399, content=<a href='/topic/show?id=09224182601' target=_blank style='color:#2F92EE;'>#基因组学#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=87, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=41826, encryptionId=09224182601, topicName=基因组学)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=c0257060332, createdName=gwc385, createdTime=Sat Nov 27 09:03:13 CST 2021, time=2021-11-27, status=1, ipAttribution=)]
    2021-11-27 crystal0564

    #结直肠#

    0

  3. [GetPortalCommentsPageByObjectIdResponse(id=1293533, encodeId=a63c12935338f, content=<a href='/topic/show?id=a82f36493c4' target=_blank style='color:#2F92EE;'>#卡培他滨#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=83, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=36493, encryptionId=a82f36493c4, topicName=卡培他滨)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=1c8c241, createdName=w363522449, createdTime=Sat Nov 27 09:03:13 CST 2021, time=2021-11-27, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1453617, encodeId=0970145361e44, content=<a href='/topic/show?id=098ee8679ad' target=_blank style='color:#2F92EE;'>#结直肠#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=74, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=78679, encryptionId=098ee8679ad, topicName=结直肠)], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=9ace5575596, createdName=crystal0564, createdTime=Sat Nov 27 09:03:13 CST 2021, time=2021-11-27, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1469733, encodeId=17d51469e3399, content=<a href='/topic/show?id=09224182601' target=_blank style='color:#2F92EE;'>#基因组学#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=87, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=41826, encryptionId=09224182601, topicName=基因组学)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=c0257060332, createdName=gwc385, createdTime=Sat Nov 27 09:03:13 CST 2021, time=2021-11-27, status=1, ipAttribution=)]
    2021-11-27 gwc385

    #基因组学#

    0

相关资讯

西妥昔单抗联合FOLFIRI 双周方案在野生型K．Ras 基因晚期结直肠癌患者中的Ⅱ期临床观察

探讨西妥昔单抗联合 FOLFIR I 双周方案治疗 K —R as 基因野生型的晚期结直肠癌的疗效及安全性。

三药联合方案治疗晚期结直肠癌的效果

结直肠癌患者确诊时约２０％以上发生远处转移，即使行根治性切除，患者也有约３５％术后复发、转移

Association between ERCC1 and TS mRNA levels and disease free survival in colorectal cancer patients receiving oxaliplatin and fluorouracil (5-FU) adjuvant chemotherapy

Colorectal cancer (CRC) is the third most common cancer worldwide and has a high mortality rate

直肠癌病例汇报

九江市第一人民医院

贞芪扶正颗粒配合化疗治疗消化道癌临床观察

观察贞芪扶正颗粒对消化道癌化疗的影响。

Folfoxiri方案在晚期结直肠癌中的应用

结直肠癌的发病率在世界各国尤其是发达国家中明显上升，近20年来在我国尤其是在大城市，结直肠癌的发病率已占消化道癌的第二位.

Baidu
map
Baidu
map
Baidu
map